InsidersTradesSigma
Track the Acorda Therapeutics, Inc. share price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was reported on 20 March 2023 (Acquisition). Among the most active insiders: COHEN RON. The full history is accessible without an account.
Analysts rate Acorda Therapeutics, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Acorda Therapeutics, Inc. 是一家生物制药公司，专注于开发神经系统疾病的治疗方法。该公司在纳斯达克上市，股票代码为ACOR。